Schedule 13D ownership disclosure

TEVA PHARMACEUTICAL INDS LTD

Security class unavailable · CUSIP: 881624209

Event date: 2017-11-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-329703
Form type
SC 13D/A
Filer
Allergan plc
CIK
CIK 1578845
Filed
Nov 01, 2017
Reporting period
Nov 01, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub